Former Bayer ANZ access leader joins global bio-revolution

By Megan Brodie 3 years ago | In Cell and gene therapies, Companies, People
  • 3 years ago
Bayer's Matt Slabbert

21 May 2021 Former Bayer ANZ Head of Market Access, Advocacy and Policy Matt Slabbert…

This is subscriber-only content. Please login to continue reading.